DataMeds AI unit reports $600K monthly revenue and new GLP-1 drugs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
August 12, 2026 7:40 AM EDTGLP-1 agonist drugs now available
Integration of online store CorexaRx.com into Health Lives Here app now complete
Medical foods Forzet & Galectovid, and dietary supplement Tollovid® now available
Revenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health
TAMPA, FL / ACCESS Newswire / August 12, 2026 /... More
